title: Bioengineered silk proteins to control cell and tissue functions.
abstract: Silks are defined as protein polymers that are spun into fibers by some lepidoptera larvae such as silkworms, spiders, scorpions, mites, and flies. Silk proteins are usually produced within specialized glands in these animals after biosynthesis in epithelial cells that line the glands, followed by secretion into the lumen of the gland prior to spinning into fibers.The most comprehensively characterized silks are from the domesticated silkworm (Bombyx mori) and from some spiders (Nephila clavipes and Araneus diadematus). Silkworm silk has been used commercially as biomedical sutures for decades and in textile production for centuries. Because of their impressive mechanical properties, silk proteins provide an important set of material options in the fields of controlled drug release, and for biomaterials and scaffolds for tissue engineering. Silkworm silk from B. mori consists primarily of two protein components, fibroin, the structural protein of silk fibers, and sericins, the water-soluble glue-like proteins that bind the fibroin fibers together. Silk fibroin consists of heavy and light chain polypeptides linked by a disulfide bond. Fibroin is the protein of interest for biomedical materials and it has to be purified/extracted from the silkworm cocoon by removal of the sericin. Characteristics of silks, including biodegradability, biocompatibility, controllable degradation rates, and versatility to generate different material formats from gels to fibers and sponges, have attracted interest in the field of biomaterials. Cell culture and tissue formation using silk-based biomaterials have been pursued, where appropriate cell adhesion, proliferation, and differentiation on or in silk biomaterials support the regeneration of tissues. The relative ease with which silk proteins can be processed into a variety of material morphologies, versatile chemical functionalization options, processing in water or solvent, and the related biological features of biocompatibility and enzymatic degradability make these proteins interesting candidates for biomedical applications.
authors.affiliation: Biomedical Engineering and Mechanical Engineering Departments, Tufts University, Medford, MA, USA.
authors.forename: Rucsanda C
authors.initials: RC
authors.lastname: Preda
authors.forename: Gary
authors.initials: G
authors.lastname: Leisk
authors.forename: Fiorenzo
authors.initials: F
authors.lastname: Omenetto
authors.forename: David L
authors.initials: DL
authors.lastname: Kaplan
mesh_terms: D000818:Animals; D001672:Biocompatible Materials / Q000737:chemistry* / Q000302:isolation & purification; D057005:Bioengineering; D012831:Bombyx; D001965:Bromides / Q000737:chemistry; D003890:Desiccation; D003956:Dialysis; D005349:Fibroins / Q000737:chemistry* / Q000302:isolation & purification; D006801:Humans; D020100:Hydrogels / Q000737:chemistry; D018020:Lithium Compounds / Q000737:chemistry; D054118:Nanospheres / Q000737:chemistry; D044968:Regenerative Medicine; D012996:Solutions; D013010:Sonication; D054457:Tissue Scaffolds / Q000737:chemistry
chemical_list: D001672:Biocompatible Materials; D001965:Bromides; D020100:Hydrogels; D018020:Lithium Compounds; D012996:Solutions; C040949:lithium bromide; D005349:Fibroins